연구동향 분석
박사

The effect of lovastatin on wound healing modulation after glaucoma filtration surgery in a rabbit model : 가토의 녹내장 여과수술 후 로바스타틴이 상처 치유에 미치는 영향

박지혜 2016년

논문상세정보
인용/피인용
' The effect of lovastatin on wound healing modulation after glaucoma filtration surgery in a rabbit model : 가토의 녹내장 여과수술 후 로바스타틴이 상처 치유에 미치는 영향' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Fibrosis
  • Filtration surgery
  • Glacuoma
  • Lovastatin
  • Rabbit
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
158 0

0.0%

' The effect of lovastatin on wound healing modulation after glaucoma filtration surgery in a rabbit model : 가토의 녹내장 여과수술 후 로바스타틴이 상처 치유에 미치는 영향' 의 참고문헌

  • Wilson HL, Schwartz DM, Bhatt HR, McCulloch CE, Duncan JL. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol 2004;137(4):615-24.
  • Villarreal G Jr, Chatterjee A, Oh SS, Oh DJ, Rhee DJ. Pharmacological regulation of SPARC by lovastatin in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2014;55(3):1657-65.
  • Turner NA, Porter KE. Function and fate of myofibroblasts after myocardial infarction. Fibrogenesis Tissue Repair 2013;6(1):5.
  • Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res 1994;59(6):723–7.
  • Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002;3(5):349-63.
  • Thomas PB, Albini T, Giri RK, See RF, Evans M, Rao NA. The effects of atorvastatin in experimental autoimmune uveitis. Br J Ophthalmol 2005;89(3):275-9.
  • Thieme H, Choritz L, Hofmann-Rummelt C, Schloetzer-Schrehardt U, Kottler UB. Histopathologic findings in early encapsulated blebs of young patients treated with the ahmed glaucoma valve. J Glaucoma 2011;20(4):246-51.
  • Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014;121(11):2081-90.
  • Stein JD, Newman-Casey PA, Talwar N, Nan B, Richards JE, Musch DC. The relationship between statin use and open-angle glaucoma. Ophthalmology 2012;119(10):2074-81.
  • Shin D, Minn KW. The effect of myofibroblast on contracture of hypertrophic scar. Plast Reconstr Surg 2004;113(2):633-40.
  • Shepard AR, Millar JC, Pang IH, Jacobson N, Wang WH, Clark AF. Adenoviral gene transfer of active human transforming growth factor-β2 elevates intraocular pressure and reduces outflow facility in rodent eyes. Invest Ophthalmol Vis Sci 2010;51(4):2067-76.
  • Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108 (Pt 3):985-1002.
  • Seibold LK, Sherwood MB, Kahook MY. Wound modulation after filtration surgery. Surv Ophthalmol 2012;57(6):530-50.
  • Seetner A, Morin JD. Healing of trabeculectomies in rabbits. Can J Ophthalmol 1979;14(2):121-5.
  • Schaafsma D, McNeill KD, Mutawe MM, Ghavami S, Unruh H, Jacques E, Laviolette M, Chakir J, Halayko AJ. Simvastatin inhibits TGFβ1-induced fibronectin in human airway fibroblasts. Respir Res 2011;12:113.
  • Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 1986;83(12):4167-71.
  • Picht G, Welge-Luessen U, Grehn F, L tjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol 2001;239(3):199–207.
  • Pena RA, Jerdan JA, Glaser BM. Effects of TGF-beta and TGF-beta neutralizing antibodies on fibroblast-induced collagen gel contraction: implications for proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1994;35(6):2804–8.
  • Ozcan AA, Ozdemir N, Canataroglu A. The aqueous levels of TGF-beta2 in patients with glaucoma. Int Ophthalmol 2004;25(1):19–22.
  • Ochiai Y, Ochiai H. Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn J Ophthalmol 2002;46(3):249–253.
  • Miller MH, Joseph NH, Ennis KW, Grierson I, Hitchings RA. An animal model of filtration surgery. Trans Ophthalmol Soc UK 1985;104:893-7.
  • Meyer-Ter-Vehn T, Katzenberger B, Han H, Grehn F, Schlunck G. Lovastatin inhibits TGF-betainduced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci 2008;49(9):3955-60.
  • McGwin G Jr, Modjarrad K, Hall TA, Xie A, Owsley C. The use of cholesterol-lowering medications and age-related macular degeneration. Ophthalmology 2005;112(3):488-94.
  • Marzilli M. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering. Am J Cardiovasc Drugs 2010;10(Suppl 1):3-9.
  • Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005;45:89-118.
  • Leung DY, Li FC, Kwong YY, Tham CC, Chi SC, Lam DS. Simvastatin and disease stabilization in normal tension glaucoma: a cohort study. Ophthalmology 2010;117(3):471-6.
  • Leske MC. Open-angle glaucoma: an epidemiologic overview. Ophthalmic Epidemiol 2007;14(4):166-72.
  • Kohno H, Sakai T, Saito S, Okano K, Kitahara K. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin. Exp Eye Res 2007;84(3):569-76.
  • Ko JH, Kim PS, Zhao Y, Hong SJ, Mustoe TA. HMG-CoA reductase inhibitors (statins) reduce hypertrophic scar formation in a rabbit ear wounding model. Plast Reconstr Surg 2012;129(2):252- 61.
  • Khaw PT, Occleston NL, Schultz G, Grierson I, Sherwood MB, Larkin G. Activation and suppression of fibroblast function. Eye (Lond) 1994;8(Pt 2):188-95.
  • Khaw PT, Chang L, Wong TT, Mead A, Daniels JT, Cordeiro MF. Modulation of wound healing after glaucoma surgery. Curr Opin Ophthalmol 2001;12(2):143–8.
  • Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120(6):701–13.
  • Inatani M, Tanihara H, Katsuta H, Honjo M, Kido N, Honda Y. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol 2001;239(2):109–13.
  • Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120(10):1268–79.
  • Hales AM, Chamberlain CG, McAvoy JW. Cataract induction in lenses cultured with transforming growth factor-beta. Invest Ophthalmol Vis Sci 1995;36(8):1709-13.
  • Fonarow GC, Watson KE. Effective strategies for long-term statin use. Am J Cardiol 2003;92(1A):27-34.
  • Fleenor DL, Shepard AR, Hellberg PE, Jacobson N, Pang IH, Clark AF. TGF beta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci 2006;47(1):226-34.
  • DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset blebrelated complications following trabeculectomy with mitomycin. Arch Ophthalmol 2002;120(3):297–300.
  • Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991;32(8):2201-11.
  • Cordeiro MF, Siriwardena D, Chang L, Khaw PT. Wound healing modulation after glaucoma surgery. Curr Opin Ophthalmol 2000;11(2):121–6.
  • Cordeiro MF, Gay JA, Khaw PT. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci 1999;40(10):2225-34.
  • Cordeiro MF, Constable PH, Alexander RA, Bhattacharya SS, Khaw PT. Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 1997;38(8):1639-46.
  • Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA 2003;290(15):2057-60.
  • Chen HY, Hsu SY, Chang YC, Lin CC, Sung FC, Chen WC, Kao CH. Association between statin use and open-angle glaucoma in hyperlipidemia patients: a Taiwanese population-based casecontrol study. Medicine (Baltimore) 2015;94(45):e2018.
  • Chen CH, Cheng CY, Chen YC, Sue YM, Hsu YH, Tsai WL, Chen TH. Rosuvastatin inhibits pressure-induced fibrotic responses via the expression regulation of prostacyclin and prostaglandin E2 in rat renal tubular cells. Eur J Pharmacol 2013;700(1-3):65-73.
  • Beckers HJ, Kinders KC, Webers CA. Five-year results of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Opthalmol 2003;241(2):106–10.
  • Barbosa DT, Mendes TS, C ntron-Colon HR, Wang SY, Bhisitkul RB, Singh K, Lin SC. Agerelated macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008. Eye (Lond) 2014;28(4):472-80
  • Anand N, Arora S, Clowes M. Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. Br J Ophthalmol 2006;90(2):175–80.
  • Agarwal P, Daher AM, Agarwal R. Aqueous humor TGF-β2 levels in patients with open-angle glaucoma: A meta-analysis. Mol Vis 2015;21:612-20.